Literature DB >> 12554153

A simple and sensitive HPLC method for determination of gliclazide in human serum.

Mohammad-Reza Rouini1, Afshin Mohajer, Mohammad-Hosein Tahami.   

Abstract

A simple, rapid and specific method for analysis of gliclazide in serum by a sensitive high-performance liquid chromatographic method is described. Only 100 microl of serum and a little sample work-up is required. A simple procedure of extraction by toluene followed by evaporation to dryness under a gentle stream of air and dissolving the dried residue in mobile was used. The gliclazide peak was separated from endogenous peaks on a C(8) column by a mobile phase of acetonitrile-water (45:55, v/v), pH 3. Gliclazide and internal standard (phenytoin) were eluted at 6.8 and 3.8 min, respectively. The limit of quantitation (LOQ) for gliclazide in serum was 75 ng/ml at 230 nm. The method was linear over the range of 75-10,000 ng/ml with r(2) of 0.999. Mean recovery for gliclazide and internal standard was 84.5 and 87%, respectively. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554153     DOI: 10.1016/s1570-0232(02)00951-0

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Gliclazide microcrystals prepared by two methods of in situ micronization: pharmacokinetic studies in diabetic and normal rats.

Authors:  Roya Talari; Jaleh Varshosaz; Saied Abolfazl Mostafavi; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2010-05-05       Impact factor: 3.246

2.  A supercritical fluid chromatography/tandem mass spectrometry method for the simultaneous quantification of metformin and gliclazide in human plasma.

Authors:  Y K Agrawal; P J Gogoi; K Manna; H G Bhatt; V K Jain
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

3.  Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats.

Authors:  Hani Al-Salami; Grant Butt; Ian Tucker; Ranko Skrbic; Svetlana Golocorbin-Kon; Momir Mikov
Journal:  Arch Drug Inf       Date:  2008-07

4.  Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats.

Authors:  Hani Al-Salami; Grant Butt; J Paul Fawcett; Ian G Tucker; Svetlana Golocorbin-Kon; Momir Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Apr-Jun       Impact factor: 2.441

5.  The influence of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes.

Authors:  Momir Mikov; Hani Al-Salami; Svetlana Golocorbin-Kon; Ranko Skrbic; Aleksandar Raskovic; J Paul Fawcett
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jul-Sep       Impact factor: 2.441

6.  Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.

Authors:  Alaa Mohamed Nazief; Passainte Saber Hassaan; Hoda Mahmoud Khalifa; Magda Samir Sokar; Amal Hassan El-Kamel
Journal:  Int J Nanomedicine       Date:  2020-02-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.